These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7675980)

  • 21. Assessing the machinery of mind: synapses in neuropsychiatric disorders.
    Honer WG
    J Psychiatry Neurosci; 1999 Mar; 24(2):116-21. PubMed ID: 10212553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deep brain stimulation in the treatment of neurological and psychiatric disease.
    Gross RE
    Expert Rev Neurother; 2004 May; 4(3):465-78. PubMed ID: 15853543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pesticides and metals induced Parkinson's disease: involvement of free radicals and oxidative stress.
    Singh C; Ahmad I; Kumar A
    Cell Mol Biol (Noisy-le-grand); 2007 May; 53(5):19-28. PubMed ID: 17543230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulatory peptides in animal paradigms of neuropsychiatric illness.
    Diamond BI; Borison RL
    Adv Biochem Psychopharmacol; 1982; 33():541-8. PubMed ID: 6214928
    [No Abstract]   [Full Text] [Related]  

  • 25. Hallmarks of protein oxidative damage in neurodegenerative diseases: focus on Alzheimer's disease.
    Polidori MC; Griffiths HR; Mariani E; Mecocci P
    Amino Acids; 2007; 32(4):553-9. PubMed ID: 17273806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Submolecular adventures of brain tyrosine: what are we searching for now?
    Kochman A; Kośka C; Metodiewa D
    Amino Acids; 2002; 23(1-3):95-101. PubMed ID: 12373523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Paradoxic sleep and neuropsychiatric illnesses].
    Kostandov EA; Lebedev BA; Monakhov KK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(1):144-9. PubMed ID: 4305513
    [No Abstract]   [Full Text] [Related]  

  • 28. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment.
    Mangialasche F; Polidori MC; Monastero R; Ercolani S; Camarda C; Cecchetti R; Mecocci P
    Ageing Res Rev; 2009 Oct; 8(4):285-305. PubMed ID: 19376275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases.
    Weinreb O; Mandel S; Amit T; Youdim MB
    J Nutr Biochem; 2004 Sep; 15(9):506-16. PubMed ID: 15350981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of neurodegenerative disorders with radical nanomedicine.
    Singh N; Cohen CA; Rzigalinski BA
    Ann N Y Acad Sci; 2007 Dec; 1122():219-30. PubMed ID: 18077575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Transitional elements and free radicals].
    Racek J; Eiselt J; Opatrný K
    Cas Lek Cesk; 2002 Aug; 141(15):479-82. PubMed ID: 12226914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidative mechanisms in nigral cell death in Parkinson's disease.
    Jenner P
    Mov Disord; 1998; 13 Suppl 1():24-34. PubMed ID: 9613715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease.
    Reddy PH
    J Neurochem; 2006 Jan; 96(1):1-13. PubMed ID: 16305625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antioxidant status and alcohol-related diseases.
    Bjørneboe A; Bjørneboe GE
    Alcohol Alcohol; 1993 Jan; 28(1):111-6. PubMed ID: 8471081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Free radicals and antioxidants: physiology, human pathology and therapeutic aspects (part II)].
    Sahnoun Z; Jamoussi K; Zeghal KM
    Therapie; 1998; 53(4):315-39. PubMed ID: 9806002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The free radical pathology and the microcirculation in the major central nervous system disorders.
    Demopoulos HB; Flamm ES; Pietronigro DD; Seligman ML
    Acta Physiol Scand Suppl; 1980; 492():91-119. PubMed ID: 6939309
    [No Abstract]   [Full Text] [Related]  

  • 37. Free radical mechanisms in schizophrenia and tardive dyskinesia.
    Cadet JL; Kahler LA
    Neurosci Biobehav Rev; 1994; 18(4):457-67. PubMed ID: 7708360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxygen free radicals and brain dysfunction.
    Jesberger JA; Richardson JS
    Int J Neurosci; 1991 Mar; 57(1-2):1-17. PubMed ID: 1938149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neuropsychiatric diseases and receptor abnormalities].
    Nihon Rinsho; 1989 Aug; 47 Suppl():1167-210. PubMed ID: 2561763
    [No Abstract]   [Full Text] [Related]  

  • 40. The opioid system in neurologic and psychiatric disorders and in their experimental models.
    Gulya K
    Pharmacol Ther; 1990; 46(3):395-428. PubMed ID: 2188270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.